Symposium:
119. Human Herpesvirus 8
Friday, October 28, 2016: 8:30 AM-10:00 AM
Room: 291-292

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • compare and contrast the distinct diseases caused by HHV8
  • explain mechanisms of pathogenesis
  • apply knowledge of pathogenesis to treatment options

Target Audience: Academicians, Clinicians, HIV specialists, Infectious diseases physicians, Investigators, Researchers, Scientists

Tracks: Adult ID, HIV-STD-TB, Investigative ID

Moderators:  Paul Griffiths, MD, DSc, University College London and Corey Casper, MD, MPH, FIDSA, Fred Hutchinson Cancer Research Center

Presentations:
8:30 AM
896
Biology of HHV8
Blossom Damania, PhD

8:55 AM
Q&A
9:00 AM
897
Diagnosis and Treatment of Kaposi's Sarcoma
Robert Yarchoan, MD

9:25 AM
Q&A
9:30 AM
898
Pathogenesis and Treatment of Castleman's Disease and Primary Effusion Lymphomas
Corey Casper, MD, MPH, FIDSA

9:55 AM
Q&A

CME Credits: Maximum of 1.5 hours of AMA PRA Category 1 Credit™

ACPE Credits: ACPE 1.5 knowledge-based contact hours 0.15 of pharmacy CE

ACPE Number: 0221-9999-16-251-L02-P

Disclosures:

P. Griffiths, None

C. Casper, Janssen Pharmaceuticals: Grant Investigator and Scientific Advisor , Research grant and Research support
Roche: Grant Investigator and Scientific Advisor , Grant recipient

See more of: Symposium
<< Previous Session | Next Session >>

Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.